White label ELPA - ClinicalTrials.eu

Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

Recruiting

2 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- RO7837195
Study of ivonescimab with chemotherapy combination for first and second-line treatment in patients with advanced or metastatic gastric and gastroesophageal cancer

Recruiting

2 1 1 1
Investigated diseases:
- Gastric cancer stage IV
- Oesophageal carcinoma
Investigated drugs:
Study of metformin for cancer prevention in adolescents and adults with Li-Fraumeni syndrome

Recruiting

3 1 1 1
Investigated drugs:
- Metformin
- Metformin Hydrochloride
Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment

Recruiting

4 1 1
Study of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread

Recruiting

1 1 1
Investigated diseases:
- Gastrointestinal carcinoma
Investigated drugs:
- GSK5764227
+4
Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

Recruiting

3 1 1 1
Investigated diseases:
- Hidradenitis
Investigated drugs:
- Sonelokimab
+7
Study of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment

Recruiting

3 1
Investigated diseases:
- Major depression
Investigated drugs:
- 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
Study of intra-articular liraglutide (4P004) for patients with knee synovitis and osteoarthritis

Recruiting

2 1
Investigated diseases:
- Synovitis
- Osteoarthritis
Investigated drugs:
- Liraglutide
Study of NT 201 compared to placebo in adults with moderate to severe platysma prominence

Recruiting

3 1
Investigated diseases:
- Muscle hypertrophy
Investigated drugs:
- Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Recruiting

3 1
Investigated diseases:
- Arteriosclerosis
+7

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies